Regency Capital Management’s Aura Biosciences AURA Stock Holding History
Bought
Maintained
Sold
Other funds holding AURA
LFCM
Regency Capital Management's AURA Position: Q3 2026 in Review
Regency Capital Management reduced its Aura Biosciences (AURA) stake by 1.4% in Q3 2026, selling an estimated $52.4K and leaving 533,068 shares worth $3.35M. The position accounts for 1.36% of the portfolio, ranked #30.
Regency Capital Management first reported a position in AURA in Q2 2022 and has held it in 18 quarters since. The position peaked at $6.57M in Q2 2023. 154 funds tracked by Wall St. Rank hold AURA as of Q3 2026.
- Regency Capital Management held 533,068 shares of Aura Biosciences worth $3.35M as of Q3 2026.
- Regency Capital Management sold 7,327 Aura Biosciences shares in Q3 2026, an estimated $52.4K.
- Aura Biosciences made up 1.36% of Regency Capital Management's portfolio in Q3 2026, its #30 holding.
- Regency Capital Management first reported a position in Aura Biosciences in Q2 2022 and has held it in 18 quarters since.
- Regency Capital Management's Aura Biosciences position peaked at $6.57M in Q2 2023.
- 154 funds tracked by Wall St. Rank held Aura Biosciences as of Q3 2026.
Based on Regency Capital Management's 13F filing for Q3 2026, filed 9 Nov 2026.